WealthPLAN Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-120
Closed -$6.67K 347
2017
Q1
$6.67K Buy
+120
New +$6.62K 0.02% 315
2016
Q3
$5.76K Sell
120
-120
-50% -$6.07K ﹤0.01% 690
2016
Q2
$6.66K Buy
+240
New +$13.2K ﹤0.01% 1882

Other funds holding PBH

WealthPLAN Partners's PBH Position: Q2 2017 in Review

WealthPLAN Partners sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 120 shares — an estimated $6.67K sold.

WealthPLAN Partners first reported a position in PBH in Q2 2016 and held it in 3 quarters. The position peaked at $6.67K in Q1 2017. 233 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • WealthPLAN Partners reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • WealthPLAN Partners sold 120 Prestige Consumer Healthcare shares in Q2 2017, an estimated $6.67K.
  • WealthPLAN Partners first reported a position in Prestige Consumer Healthcare in Q2 2016 and held it in 3 quarters.
  • WealthPLAN Partners's Prestige Consumer Healthcare position peaked at $6.67K in Q1 2017.
  • 233 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on WealthPLAN Partners's 13F filing for Q2 2017, filed 11 Aug 2017.